The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People
Open accessAbstract
OBJECTIVE: To identify biomarker patterns typical for Alzheimer disease (AD) in an independent, unsupervised way, without using information on the clinical diagnosis. DESIGN: Mixture modeling approach. SETTING: Alzheimer's Disease Neuroimaging Initiative database. PATIENTS OR OTHER PARTICIPANTS: Cognitively normal persons, patients with AD, and individuals with mild cognitive impairment. MAIN OUTCOME MEASURES: Cerebrospinal fluid-derived beta-amyloid protein 1-42, total tau protein, and phosphorylated tau(181P) protein concentrations were used as biomarkers on a clinically well-characterized data set. The outcome of the qualification analysis was validated on 2 additional data sets, 1 of which was autopsy confirmed. RESULTS: Using the US Alzheimer's Disease Neuroimaging Initiative data set, a cerebrospinal fluid beta-amyloid protein 1-42/phosphorylated tau(181P) biomarker mixture model identified 1 feature linked to AD, while the other matched the "healthy" status. The AD signature was found in 90%, 72%, and 36% of patients in the AD, mild cognitive impairment, and cognitively normal groups, respectively. The cognitively normal group with the AD signature was enriched in apolipoprotein E epsilon4 allele carriers. Results were validated on 2 other data sets. In 1 study consisting of 68 autopsy-confirmed AD cases, 64 of 68 patients (94% sensitivity) were correctly classified with the AD feature. In another data set with patients (n = 57) with mild cognitive impairment followed up for 5 years, the model showed a sensitivity of 100% in patients progressing to AD. CONCLUSIONS: The mixture modeling approach, totally independent of clinical AD diagnosis, correctly classified patients with AD. The unexpected presence of the AD signature in more than one-third of cognitively normal subjects suggests that AD pathology is active and detectable earlier than has heretofore been envisioned.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Abnormal CSF Aβ42 values were defined using the previously established cut-off of <192 ng/L57–59.”
From Earliest accumulation of β-amyloid occurs within the default-mode network and concurrently affects brain connectivity (2017) · cites this paper as [58]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Elements of Statistical Learning
Hastie, T., Friedman, J., & Tibshirani, R. (2001) · Springer Series in Statistics · doi:10.1007/978-0-387-21606-5 · Cited by 24,162
Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS–ADRDA criteria
Dubois, B., Feldman, H. H., Jacova, C., DeKosky, S. T., Barberger-Gateau, P., Cummings, J., Delacourte, A., Galasko, D., Gauthier, S., Jicha, G., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70178-3 · Cited by 4,411
ROCR: visualizing classifier performance in R
Sing, T., Sander, O., Beerenwinkel, N., & Lengauer, T. (2005) · Computer applications in the biosciences · doi:10.1093/bioinformatics/bti623 · Cited by 3,172
Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects
Shaw, L. M., Vanderstichele, H., Knapik‐Czajka, M., Clark, C. M., Aisen, P. S., Petersen, R. C., Blennow, K., Soares, H., Simon, A., Lewczuk, P., et al. (2009) · Annals of Neurology · doi:10.1002/ana.21610 · Cited by 2,065
Hansson, O., Zetterberg, H., Buchhave, P., Londos, E., Blennow, K., & Minthon, L. (2006) · The Lancet Neurology · doi:10.1016/s1474-4422(06)70355-6 · Cited by 1,700
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans
Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S., Dence, C. S., Shah, A. R., LaRossa, G. N., Spinner, M. L., Klunk, W. E., Mathis, C. A., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20730 · Cited by 1,246
Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins
Ray, S., Britschgi, M., Herbert, C., Takeda-Uchimura, Y., Boxer, A., Blennow, K., Friedman, L. F., Galasko, D. R., Jutel, M., Karydas, A., et al. (2007) · Nature Medicine · doi:10.1038/nm1653 · Cited by 1,048
Pike, K. E., Savage, G., Villemagne, V. L., Ng, S., Moss, S. A., Maruff, P., Mathis, C. A., Klunk, W. E., Masters, C. L., & Rowe, C. C. (2007) · Brain · doi:10.1093/brain/awm238 · Cited by 789
Improved discrimination of AD patients using β-amyloid (1-42) and tau levels in CSF
Hulstaert, F., Blennow, K., Ivanoiu, A., Schoonderwaldt, H. C., Riemenschneider, M., Deyn, P. P. D., Bancher, C., Cras, P., Wiltfang, J., Mehta, P. D., et al. (1999) · Neurology · doi:10.1212/wnl.52.8.1555 · Cited by 724
Two-year follow-up of amyloid deposition in patients with Alzheimer's disease
Engler, H., Forsberg, A., Almkvist, O., Blomquist, G., Larsson, E., Savitcheva, I., Wall, A. E., Ringheim, A., Långström, B., & Nordberg, A. K. (2006) · Brain · doi:10.1093/brain/awl178 · Cited by 614
Cited by
Sorted by citations
Items 401–455 of 455
Hansson, J. (2016) · KTH Publication Database DiVA (KTH Royal Institute of Technology)
Modeling the Early Identification and Intervention of Alzheimer’s Disease
Michaud, T. L. (2015) · University of Minnesota Digital Conservancy (University of Minnesota)
AD BIOMARKERS YEARS BEFORE ONSET OF SYMPTOMS
Valeo, T. (2010) · Neurology Today · doi:10.1097/01.nt.0000388906.49858.07
Evaluation and management of dementia
Collins, L., Rovner, B. W., & Collins-Fletcher, K. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107294967.010
Diagnostiquer la maladie d'Alzheimer
Sarazin, M., Hamelin, L., Lamari, F., & Bottlaender, M. (2013)
Diagnosis-Independent Cerebrospinal Fluid Biomarkers of Alzheimer Disease
Marshall, G. A. (2010) · Journal watch · doi:10.1056/jn201011020000002
Weiner, M. W., Veitch, D. P., Hayes, J., Neylan, T. C., Grafman, J. H., Aisen, P. S. S., Petersen, R. C., Jack, C. R., Jagust, W., Trojanowski, J. Q., et al. (2014)
Charakterisierung von Prädiktoren rapid-progressiver Verläufe des M. Alzheimer
Bartlau, T. (2016) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5745
Identifying stage-specific markers of Alzheimer's disease using quantitative proteomics
Yagensky, O. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7052
Theoretical and Numerical Analysis of a Novel Electrically Small and Directive Antenna
Elloian, J. M. (2014) · Digital WPI
Mental Health Laws from All UK Jurisdictions
Burrell, C., & Emmett, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.024
Wang, Z. (2019) · Biostatistics & Epidemiology · doi:10.1080/24709360.2019.1673623
Epidemiology and Mental Health in Old Age
Lilford, P., & Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.004
Яхьяевич, Я. Н., & Vagabov, N. M. (2009) · VESTNIK OF ASTRAKHAN STATE TECHNICAL UNIVERSITY SERIES MARINE ENGINEERING AND TECHNOLOGIES
Mental Health in Parkinson’s Disease
Jones, S., Torsney, K., Scourfield, L., Berryman, K., & Henderson, E. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.011
Mitchell, A. J. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.014
Hughes, J. C., Poole, M., Louw, S., Greener, H., & Emmett, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.026
Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.028
Series, H. G., & Esiri, M. M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.005
Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.003
Supporting Self-Management in Early Dementia
Cheffey, J., Hill, L., & Roberts, G. A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.017
Brindle, N., & Walsh, C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.025
Colgate, R., Turner, A., & Rafferty, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.023
The Home Assessment in Old Age Psychiatry
Ng, B., & Atkins, M. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.012
Jefferies, K., & Agrawal, N. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.006
Richards, F., & Curtice, M. J. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.008
Hughes, J. C., Jolley, D. J., Jordan, A., & Sampson, E. L. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.020
Wagle, A., & Badrakalimuthu, V. R. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.010
Reducing the Healthcare Burden of Delirium
Meagher, D. J., O'Connell, H. P., Cullen, W., & Adamis, D. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.022
Gupta, S., Fiertag, O., Thanulingam, T., Strange, B. A., & Warner, J. P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.007
Wilson, S., & Pinner, G. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.013
Hughes, J. C., & Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.001
Biomarkers and the Diagnosis of Preclinical Alzheimer’s Disease
Lilford, P., & Hughes, J. C. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.015
Understanding the Person with Dementia
Hughes, J. C., & Beatty, A. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.027
Hughes, J. C., & Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.002
Sullivan, V., Majumdar, B., Richman, A. V., & Vinjamuri, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.016
Decoding the Epigenome of Neuronal Networks in Health and Disease
Jain, G. (2019) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7477
Saint‐Aubert, L. (2012) · Thèses en ligne de l'Université Toulouse III (Université Toulouse III)
Hughes, J. C., & Lilford, P. (2020) · Cambridge University Press eBooks · doi:10.1017/9781108594714.029
Novel perspectives from existing data on early Alzheimer’s disease pathology and dementia care use
Janssen, O. (2022) · Research Publications (Maastricht University) · doi:10.26481/dis.20220617oj
(2014) · Wiley eBooks · doi:10.1002/9781394260447.biblio
Duits, F. H., Wesenhagen, K. E. J., Ekblad, L. L., Wolters, E. E., Willemse, E. A. J., Scheltens, P., van der Flier, W. M., Teunissen, C. E., Visser, P. J., & Tijms, B. M. (2021) · Figshare · doi:10.6084/m9.figshare.13521232
(2012) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-62396-048-320251027
Duits, F. H., Wesenhagen, K. E. J., Ekblad, L. L., Wolters, E. E., Willemse, E. A. J., Scheltens, P., van der Flier, W. M., Teunissen, C. E., Visser, P. J., & Tijms, B. M. (2021) · Figshare · doi:10.6084/m9.figshare.13521229
Flores-Aguilar, L., Iulita, M. F., Orciani, C., Tanna, N., Yang, J., Bennett, D. A., & Cuello, A. C. (2021) · Figshare · doi:10.6084/m9.figshare.14908162
Flores-Aguilar, L., Iulita, M. F., Orciani, C., Tanna, N., Yang, J., Bennett, D. A., & Cuello, A. C. (2021) · Figshare · doi:10.6084/m9.figshare.14908153
Martínez‐Dubarbie, F., Guerra-Ruiz, A., López‐García, S., Lage, C., Fernández‐Matarrubia, M., Infante, J., Pozueta‐Cantudo, A., García-Martínez, M., Corrales‐Pardo, A., Bravo, M., et al. (2024) · Figshare · doi:10.6084/m9.figshare.26621608
Flores-Aguilar, L., Iulita, M. F., Orciani, C., Tanna, N., Yang, J., Bennett, D. A., & Cuello, A. C. (2021) · Figshare · doi:10.6084/m9.figshare.14908147
Hu, Q., Shi, M., Li, Y., & Zhao, X. (2024) · Figshare · doi:10.6084/m9.figshare.26744834
Flores-Aguilar, L., Iulita, M. F., Orciani, C., Tanna, N., Yang, J., Bennett, D. A., & Cuello, A. C. (2021) · Figshare · doi:10.6084/m9.figshare.14908144
(2011) · Emerald Group Publishing Limited eBooks · doi:10.1108/978-1-61735-389-520251017
Sarkar, R., Kabra, A., Saeedan, A. S., & Ansari, M. N. (2026) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.6c00440
Liquormarker Aß 1-42, T-Tau und P-Tau in der Differenzialdiagnostik der Demenzen
Kaerst, L. (2014) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-4595
Metadata
- Authors
- De Meyer, G.
- Venue
- Archives of Neurology
- Publisher
- American Medical Association (AMA)
- Published
- 2010-08-01
- Volume
- 67
- Issue
- 8
- Pages
- 949
- ISSN
- 0003-9942 (ISSN-L)
- PMC
- PMC2963067
- OpenAlex
- W2141854336
- Cited by
- 462
- References
- 24
- Citations by year
- 2026: 4 · 2025: 14 · 2024: 14 · 2023: 8 · 2022: 13 · 2021: 18 · 2020: 43 · 2019: 16 · 2018: 19 · 2017: 24 · 2016: 15 · 2015: 31 · 2014: 44 · 2013: 35 · 2012: 58
- FWCI
- 42.86
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Archives of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Lund University Publications (Lund University) (submittedVersion)
- VUBIR (Vrije Universiteit Brussel) (submittedVersion)
- Funders
- National Institutes of Health (5u01ag024904-10)
- National Institute on Aging (U01-AG-024904, P30AG010124, U19AG010483)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Oncology › Cancer-related cognitive impairment studies
- Keywords
- Alzheimer's disease, biomarker signatures, cerebrospinal fluid, amyloid-beta 42, phosphorylated tau, total tau, mixture models, cognitively normal elderly, mild cognitive impairment, APOE ε4, unsupervised classification
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Cognition, Female, Follow-Up Studies, Humans, Male, Peptide Fragments, ROC Curve, Reproducibility of Results, Biomarkers, Geriatric Assessment, Amyloid beta-Peptides, tau Proteins, Apolipoprotein E4
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
